Title:
【発明の名称】〔1,2,4〕トリアゾロ〔4,3-a〕キノキサリノン誘導体、それらの調製方法及び使用
Document Type and Number:
Japanese Patent JPH10506620
Kind Code:
A
Abstract:
[1,2,4]triazolo[4,3-a]quinoxalinone compounds of general formula (I) wherein R<1> is POX'X" or alkyl substituted with COX' or POX'X", and X' and X" independently are hydroxy or alkoxy, and R<6>, R<7>, R<8> and R<9> independently are hydrogen; alkyl; halogen; NH2; NO2; CN; CF3 SO2NY'Y" or COZ' wherein Z' is NY'Y" or alkyl and Y' and Y" independently are hydrogen or alkyl; triazolyl; imidazolyl or imidazolyl substituted with phenyl or alkyl, are useful in the treatment of indications caused by hyperactivity of the excitatory neurotransmitters.
More Like This:
Inventors:
Fleming Ermelund, Nielsen
Application Number:
JP50982896A
Publication Date:
June 30, 1998
Filing Date:
September 12, 1995
Export Citation:
Assignee:
Novo Nordisk Actiesel Scab
International Classes:
A61K31/495; A61P1/08; A61P3/08; A61P9/00; A61P25/00; A61P25/08; A61P25/28; A61P29/00; C07D487/04; (IPC1-7): C07D487/04; A61K31/495
Attorney, Agent or Firm:
Takashi Ishida (3 others)